Effect of Pomegranate Seed Powder on Markers of Metabolic Syndrome
NCT ID: NCT05944029
Last Updated: 2023-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2023-02-20
2023-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pomegranate Consumption by Poly-medicated Metabolic Syndrome Patients
NCT04075032
Effect of Fenugreek and Cumin Powder on Overweight and Obese People
NCT05966935
Effect of Fenugreek Seed Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
NCT07056712
Effect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese People
NCT06626867
Comparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade I
NCT05770791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
seed powder can influence the patient's metabolic syndrome-related indicators.
Hypothesis:
Pomegranate seed powder can be effective to treat the individuals with impaired metabolism.
Methodology:
In a clinical trial, patients of metabolic syndrome (n=50) will be given pomegranate seed powder dose for over 8 weeks, twice a day. Biochemical outcomes including blood pressure, FBG, cholesterol, hemoglobin level will be determined before and after the completion of trial in addition to patient's weight. Finally, using one-way ANOVA and T-test, collected data will be analyzed.
Expected outcome: The study will explore the potential of pomegranate seed powder in treating metabolic syndrome's risk factors. Therefore, our findings on the studied parameters of patient will assist future researchers in developing tested, evidence-based recommendations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metabolic syndrome Patients
Pomegranate seed powder is administered for alleviating symptoms of metabolic syndrome
Pomegranate seed powder
10 g powder / day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pomegranate seed powder
10 g powder / day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dyslipidemia
* Altered blood glucose level
* Age 30-55 ( male and female)
Exclusion Criteria
* Liver disease
* Kidney disorder
* Cancer etc
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asif Ali
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asif Ali
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Asif Ali, Mphil
Role: STUDY_DIRECTOR
University of Veterinary and Animal Sciences Lahore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Veterinary and Animal sciences Lahore
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UVAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.